Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2003

01-11-2003 | Concise Article

Pulmonary Aspergillosis in a Patient with Chronic Granulomatous Disease: Confirmation by Polymerase Chain Reaction and Serological Tests, and Successful Treatment with Voriconazole

Authors: H. Sambatakou, M. Guiver, D. Denning

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2003

Login to get access

Abstract

A 25-year-old male with chronic granulomatous disease developed severe bilateral pulmonary aspergillosis confirmed by a positive result of polymerase chain reaction for Aspergillus species from sputum and positive serological tests for Aspergillus. He was successfully treated with voriconazole. The diagnostic difficulties and the new therapeutic options in the era of new antifungal agents are discussed.
Literature
1.
Dinauer M, Orkin S, Brown R, Jesaitis A, Parkos C (1987) The glycoprotein encoded by the X-linked chronic granulomatous disease locus in a component of the neutrophil cytochrome b complex. Nature 327:717–720CrossRefPubMed
2.
Jirapongsananuruk O, Niemela JE, Malech HL, Fleisher TA (2002) CYBB mutation analysis in X-linked chronic granulomatous disease. Clin Immunol 104:73–76CrossRefPubMed
3.
Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114:555–560PubMed
4.
Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ (1990) Prognosis of chronic granulomatous disease. Arch Dis Child 65:942–945PubMed
5.
Loeffler J, Schmidt K, Hebart H, Schumacher U, Einsele H (2002) Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system. J Clin Microbiol 40:2240–2243CrossRefPubMed
6.
Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33:1504–1512PubMed
7.
Liese J, Kloos S, Jendrossek V, Petropoulou T (2000) Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687–693PubMed
8.
Casson DH, Riordan FA, Ladusens EJ (1996) Aspergillus endocarditis in chronic granulomatous disease. Acta Paediatr 85:758–759PubMed
9.
Gupta PK, Mahapatra AK, Gaind R, Bhandari S, Musa MM, Lad SD (2001). Aspergillus spinal epidural abscess. Pediatr Neurosurg 35:18–23CrossRefPubMed
10.
Margolis DM, Melnick DA, Alling DW, Gallin JI (1990) Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 162:723–726PubMed
11.
Progrebniak H, Gallin J, Malech H, Baker A, Moskaluk C, Travis W, Pass H (1993) Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann Thorac Surg 55:844–849PubMed
12.
Roilides E, Sigler L, Bibashi E, Katsifa H, Flaris N, Panteliadis C (1999) Disseminated infection due to Chrysosporium zonatum in a patient with chronic granulomatous disease and review of non-Aspergillus fungal infections in patients with this disease. J Clin Microbiol 37:18–25PubMed
13.
Jabado N, Casanova JL, Haddad E, Dulieu F, Fournet JC, Dupont B, Fischer A, Hennequin C, Blanche S (1998) Invasive pulmonary infection due to Scedosporium apiosperum in two children with chronic granulomatous disease. Clin Infect Dis 27:1437–1441PubMed
14.
Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998–1003PubMed
15.
Casale TB, Macher AM, Fauci AS (1984) Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. South Med J 77:274–275PubMed
16.
Olive D, Burioti D, Brocard O, Griscelli C (1979) Pulmonary aspergillosis and chronic septic granulomatosis. Arch Fr Pediatr 36:298–302PubMed
17.
Abati A, Cajigas A, Holland SM, Solomon D (1996) Chronic granulomatous disease of childhood: respiratory cytology. Diagn Cytopathol 15:98–102CrossRefPubMed
18.
Dorman SE, Guide SV, Conville PS, DeCarlo ES, Malech HL, Gallin JI, Witebsky FG, Holland SM (2002) Nocardia infection in chronic granulomatous disease. Clin Infect Dis 35:390–394CrossRefPubMed
19.
Roback SA, Weintraub WH, Good RA et al. (1971) Chronic granulomatous disease of childhood: surgical considerations. J Pediatr Surg 6:601–611PubMed
20.
Bretagne S, Costa MJ, Bart-Delabesse E, Dhedin N, Rieux C, Cordonnier C (1998) Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 26:1407–1412PubMed
21.
Verweij PE, Latge JP, Rijs AJMM, Melchers WJG, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM (1995) Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for haematological malignancies. J Clin Microbiol 33:3150–3153PubMed
22.
Ascioglou S, Rex JH, de Pauw B, Bennet JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34:7–14PubMed
23.
Tsuge I, Makimura K, Natsume J, Kubota T, Hasegawa S, Kawabe T, Nakashima S, Aso K, Negoro T, Watanabe K (1998) Successful polymerase chain reaction-based diagnosis of fungal meningitis in a patient with chronic granulomatous disease. Acta Paediatr Jpn 40:356–359PubMed
24.
Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Elderle J, Verbist L, Boogaerts M (1999) Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 37:3223–3228PubMed
25.
Verweij PE, Weemaes CM, Curfs Jo HAJ, Bretagne S, Meis JFGM (2000) Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 38:3900–3901PubMed
26.
Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C (1999) Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol 104:1265–1272PubMed
27.
Saulsbury FT (2001) Successful treatment of Aspergillus brain abscess with itraconazole and interferon-gamma in a patient with chronic granulomatous disease. Clin Infect Dis 32:137–139CrossRef
28.
Spencer DA, John P, Ferryman SR, Weller PH, Darbyshire P (1994) Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am J Respir Crit Care Med 149:239–241PubMed
29.
Kloss S, Schuter A, Schroten H, Lamprecht J, Wahn V (1991) Control of proven pulmonary and suspected CNS Aspergillus infection with itraconazole in a patient with chronic granulomatous disease. Eur J Pediatr 150:483–485PubMed
30.
Bernhisel-Broadbent J, Camargo EE, Jaffe HS, Lederman HM (1991) Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis 163:908–911PubMed
31.
Touza Rey F, Martinez Vasquez C, Alonso Alonso J, Mendez Pineiro MJ, Rubianes Gonzalez M, Crespo Casal M (2000) The clinical response to interferon-gamma in a patient with chronic granulomatous disease and brain abscesses due to Aspergillus fumigatus. Ann Intern Med 17:86–87
32.
Denning WD, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34:563–571CrossRefPubMed
33.
Herbrecht R, Denning WD, Patterson FT, Bennett EJ, Greene ER, Oestmann WJ, Kern VW, Marr K, Ribaud P, Lortholary O et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415PubMed
34.
Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR (2002) Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 21:240–248PubMed
35.
Hek LG van’t, Verweij PE, Weemaes CM, Dalen R van, Yntema JB, Meis JF (1998) Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 157:1694–1696PubMed
36.
Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud J (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMed
Metadata
Title
Pulmonary Aspergillosis in a Patient with Chronic Granulomatous Disease: Confirmation by Polymerase Chain Reaction and Serological Tests, and Successful Treatment with Voriconazole
Authors
H. Sambatakou
M. Guiver
D. Denning
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1007-2

Other articles of this Issue 11/2003

European Journal of Clinical Microbiology & Infectious Diseases 11/2003 Go to the issue

Brief Report

Reference Values for the SERION classic ELISA for Detecting Legionella pneumophila Antibodies

Concise Article

Rapid Identification of Yeasts Commonly Found in Positive Blood Cultures by Amplification of the Internal Transcribed Spacer Regions 1 and 2

Brief Report

Micrococcus Infection in Patients Receiving Epoprostenol by Continuous Infusion

Concise Article

Comparison of a Commercial Reversed Passive Latex Agglutination Assay to an Enzyme Immunoassay for the Detection of Shiga Toxin-Producing Escherichia coli

Concise Article

Pulmonary Mycobacterium xenopi Infection in AIDS Patients Treated with HAART in Hungary

Article

External Quality Control of Direct Antigen Tests to Detect Group A Streptococcal Antigen
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits